PubMed Health⌕ Search

Biomedical subjects

W Magliani

Publications and source records attributed to W Magliani.

31 records · Page 2Linked to original sources

Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.

The principles of idiotypic (Id) vaccination were used to immunize against vaginitis caused by Candida albicans, a widespread and sometimes intractable disease in women. To this aim, a murine mAb (KT4, IgG1) neutralizing in vitro the anti-Candida activity of a yeast killer toxin (YKT) was used as an Id vaccine to elicit Abs with toxin-like activity in a rat vaginitis model. Nonimmunized and isotype-matched, irrelevant mAb-immunized rats served as controls. An effective protection was obtained in Id-vaccinated animals, as demonstrated by a highly significant decrease in vaginal Candida CFU compared with controls. The protection was associated with rising vaginal titers of anti-idiotypic Abs (IdAb), prevalently of the IgA isotype, that were able to passively transfer the protective state to nonimmunized animals. The vaginal IdAb possessed YKT-like activity because they were able to kill in vitro the challenging fungal cells, and this killing was neutralized by the mAb KT4. Overall, these data demonstrate that secretory IdAb elicited by intravaginal Id vaccination with mAb KT4 protected the rats from the infectious challenge with Candida albicans by molecular mimicking YKT activity as its internal image.

Animals↗

Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity.

Anti-Id antibodies were raised in mice against a monoclonal antibody (MoAb KT4) that neutralized the in vitro activity of a Pichia anomala yeast killer toxin. Monoclonal antibody was administered to BALB/C syngeneic mice with different schedules of immunization before intravenous challenge with increasing amounts of yeast killer toxin-sensitive Candida albicans cells. The course of candidosis was studied in comparison with mice non-immunized and immunized with an isotype-matched unrelated MoAb subdivided into control groups. Protection was reflected by statistically significant increases in survival rate of mice immunized with MoAb KT4 which showed variable serum levels of yeast killer toxin-like anti-Id antibodies. MoAb KT4 affinity chromatography purified mouse anti-Id antibodies were capable of killing in vitro the yeast cells of the Candida albicans strain used for the experimental infection. This is the first report of antimicrobial protection that exploits the role of anti-idiotypic antibodies presumably acting in vivo as antibiotics (idiotypic vaccination).

Animals↗

'Antibiobodies': antibiotic-like anti-idiotypic antibodies.

Pathogenic micro-organisms such as Candida albicans may be susceptible to the activity of antimicrobial products like yeast killer toxins due to the presence of specific cell wall receptors for these agents. Anti-idiotypic antibodies (anti-Ids) were produced that competed for these receptors with the yeast killer toxin of a strain of Pichia anomala. We report here that affinity chromatography purified anti-Ids may kill C. albicans cells in vitro which are susceptible to the activity of the yeast killer toxin, as well as P. anomala killer cells which are obviously immune to their own toxin despite possessing specific cell wall receptors which can be detected by indirect immunofluorescence with anti-Ids. We propose that these conceptually new antimicrobial immunoglobulins acting as antibiotics be called 'antibiobodies'.

Anti-Bacterial Agents↗

Interfaces of the yeast killer phenomenon.

A new prophylactic and therapeutic antimicrobial strategy based on a specific physiological target that is effectively used by killer yeasts in their natural ecological competition is theorized. The natural system exploited is the yeast killer phenomenon previously adopted as an epidemiological marker for intraspecific differentiation of opportunistic yeasts, hyphomycetes, and bacteria. Pathogenic microorganisms (Candida albicans) may be susceptible to the activity of yeast killer toxins due to the presence of specific cell wall receptors. On the basis of the idiotypic network, we report that antiidiotypic antibodies, produced against a monoclonal antibody bearing the receptor-like idiotype, are in vivo protecting animals immunized through idiotypic vaccination and in vitro mimicking the antimicrobial activity of yeast killer toxins, thus acting as antibiotics.

Adsorption↗

[Diagnostic significance of secretory IgA coated yeast cells in oral candidiasis].

The significance of in vivo IgA coated yeast cells for the diagnosis of candidiasis of the oral mucosal membranes was evaluated by direct immunofluorescence in 42 patients with or without clinical symptoms, shown to be positive for yeast growth in the cultural test. Most of the patients with clinically suspected candidiasis of the mucosal membranes gave positive results by serologic assays in contrast to the majority of symptomless patients. The diagnostic approach proved to be essentially consistent with the clinical signs, persistance of infection, response to antifungal therapy and quantitative cultural data.

Biomarkers↗

Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies.

Biotyping of pathogenic yeasts and hyphomycetes based on their susceptibility to selected killer yeasts and their reactivity with monoclonal antibodies are described. Both methods were used to differentiate fungi isolated from patients providing valuable epidemiological information on mycotic infections. The functional biotyping obtained with the two systems and the conventional auxenographic biocoding approaches commercially available for opportunistic yeasts are comparatively evaluated. The potential for biotyping of industrial fungal isolates is also discussed.

Antibodies, Monoclonal↗

Epidemiological survey on bacterial, viral and parasitic agents in patients affected by acute enteritis.

During the period June 1983-May 1984, faecal specimens from 797 patients with acute enteritis were examined for the presence of bacterial, viral and parasitic agents; 209 (26.2%) enteritic pathogens were identified, of whom 118 (35.4%) in 333 samples from the pediatrics wards. Bacterial agents were detected in 122 (15.3%), viruses in 63 (7.9%) and parasites in 25 (3.1%) of the 797 specimens. LT-producing E. coli, Salmonella and Rotavirus were the most frequent pathogens. Bacterial agents occurred most frequently in the summer and autumnal months, whereas viruses showed two peaks, the first one in summer due to cultivable agents, the second in winter to Rotavirus mainly.

Acute Disease↗

[Reliability of the bacterial identification tests and of antibiotic sensitivity tests made with automatic methods].

A "MS-2 Microbiology System" (Abbott) has been used to identify and to assess the susceptibility patterns of clinically isolated bacteria from highly compromised patients. Automatically obtained results by the analysis of 300 specimens were compared to those of traditional methods. The automated system was in good agreement with API (81%) while in 4% of the strains there were major discrepancies, and 5% of the experiments were carried out with slow growing bacteria which normally give poor results in automatic systems. Antimicrobial susceptibility testing was satisfactory in 84% of the specimens with 7% of minor discrepancies and 9% of major ones. The evaluation of MIC for slow growing organisms like Haemophilus, Diplococcus and anaerobes belonging to the Bacteroides genus, was the same using either automatic or standard procedures.

Anti-Bacterial Agents↗

[Automated direct antimicrobial susceptibility testing of urine specimens].

Two microscopical screening methods have been used to assay the suitability of urine samples for automated direct antimicrobial susceptibility testing by the means of a "MS-2 Microbiology System" apparatus. Gram stained smears showed if specimens were monomicrobic and fresh-mount bacterioscopy gave information about presumptive counts to establish inoculum size. The results obtained by the automated method have been compared with those of the direct disk diffusion method and the classical Stokes method on a single isolated colony. The three systems were reliable and only 7% of specimens gave major discrepancies and 15% minor errors. The influence of each antibiotic drug and of each bacterial species on the discrepancies has been discussed. Direct susceptibility testing by MS-2 seems to be accurate and in the same time so fast (5-6 h vs. 18-24 h) to appear very useful in the rational guide of chemotherapy in the more severe UTI.

Anti-Bacterial Agents↗